Trial Profile
Clinical Trials Insight: 700014739
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 06 Sep 2006
Price :
$35
*
At a glance
- Drugs VIR 201 (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Prescient Therapeutics
- 06 Sep 2006 New trial record.